Sumitomo Dainippon Pharma Annual Report 2017
69/102

$ 357,143 160,715946450,11613,339464,40178,732880,02798,6872,039,705 89,286120,518356,330290,92979,071936,134200,000141,6163,246,678 (5,955)3,582,339164,643(179) 408,286(42,080)530,6704,113,009$ 7,088,848¥ 1,01022,0009342,4361,11143,64026,35879,2977,418179,72328,00016,1598,96816,20912,18581,521 22,400 15,861341,402(663)379,00025,293(13)48,025(5,832)67,473446,473¥ 707,717¥ 40,00018,00010650,4131,49452,0138,81898,56311,053228,44710,00013,49839,90932,5848,856104,847 22,400 15,861363,628(667)401,22218,440(20)45,728(4,713)59,435460,657¥ 793,951CURRENT LIABILITIES: Short-term loans payable (Note 5 and 8) Current portion of long-term debt (Notes 5 and 8) Payables: Trade notes (Note 5) Trade accounts (Notes 5, 6 and 7) Due to parent company, unconsolidated subsidiaries and afliates (Notes 5 and 13) Total Income taxes payable (Note 5) Accrued expenses Other current liabilities Total current liabilities LONG-TERM LIABILITIES: Long-term debt (Notes 5 and 8) Liability for retirement benets (Note 10) Fair value of contingent consideration Deferred tax liabilities (Note9) Other liabilities (Note 8) Total long-term liabilities COMMITMENTS AND CONTINGENT LIABILITIES (Notes 14 and 20): NET ASSETS: Shareholders’ equity (Note 11) Common stock: authorized — 1,500,000,000 shares in the years ended March 31, 2017 and 2016; issued — 397,900,154 shares in the years ended March 31, 2017 and 2016 Capital surplus Retained earnings Treasury stock, at cost:600,484 shares in the year ended March 31, 2017 and 598,599 shares in the year ended March 31, 2016 Total shareholders’ equity Accumulated other comprehensive income (loss) Unrealized gains (losses) on available-for-sale securities Deferred gains (losses) on hedges Foreign currency translation adjustments Remeasurements of dened benet plans Total accumulated other comprehensive income (loss) Total net assetsTOTAL LIABILITIES AND NET ASSETSSee Notes to Consolidated Financial Statements.Millions of yenThousands ofU.S. dollars (Note 1)20162017201768Sumitomo Dainippon Pharma Co., Ltd. Annual Report 2017

元のページ  ../index.html#69

このブックを見る